 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Merck KGaA, MDxHealth Explore Personalized Rx Strategy for Glioblastoma Patients with Methylated MGMT
July 11, 2012
Merck KGaA, MDxHealth Explore Personalized Rx Strategy for Glioblastoma Patients with Methylated MGMT
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MDxHealth, Merck KGaA Expand Glioblastoma Drug-CDx Deal
July 5, 2012 / GenomeWeb Daily News - MDx/PGx Highlights from ASCO 2011
June 15, 2011 / Pharmacogenomics Reporter - MDxHealth's Q1 Revenues Jump More Than 50 Percent
May 7, 2013 / GenomeWeb Daily News - McGill Team Lands $5M for Pediatric Glioblastoma Dx Study
April 17, 2013 / GenomeWeb Daily News - MDxHealth's Irvine Laboratory Receives ISO 9001:2008 Certification
April 2, 2013 / GenomeWeb Daily News